Spinal Disc Therapy
Our Chief Scientific Officer, Thomas Ichim, Ph.D. led a team in a thorough analysis of the advantage fibroblasts exhibit over mesenchymal stem cells.
A team of scientists led by Howard An, M.D. proves human dermal fibroblasts are a promising future for treatment of degenerative disc disease. Read More
Under the direction of Antonios Mikos, Ph.D., human dermal fibroblasts were successfully differentiated into chondrocytes in an environment which simulated the spine. Read More
16815 Royal Crest Drive, Suite 100
Houston, TX 77058